For many investors, the main point of stock picking is to generate higher returns than the overall market. But if ...

In 2022, pharmaceutical giant Pfizer (NYSE: PFE) became the first healthcare company to generate $100 billion in annual sales ...

The stock has spent the past few years in the shadow of a COVID-19 boost, but it's time investors see the light.

In 2024, companies in the broader market that paid dividends returned around 35% of their net income and 45% of their free ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 0.03% of ...

Pfizer Inc (PFE) stock saw a decline, ending the day at $26.3 which represents a decrease of $-0.19 or -0.72% from the prior close of $26.49. The stock opened at $26.4 and touched a low of $26.22 ...

We recently published a list of 12 Undervalued Defensive Stocks for 2025. In this article, we are going to take a look at ...

Pfizer Inc. (NYSE:PFE – Get Free Report) traded down 0.9% during mid-day trading on Wednesday after UBS Group lowered their price target on the stock from $31.00 to $29.00. UBS Group currently has a ...

Pfizer (PFE) is one of the stocks most watched by ... between trends in earnings estimate revisions and short-term stock price movements. Pfizer is expected to post earnings of $0.48 per share ...